AGRX Agile Therapeutics Inc

19,612

$2.40

$0.22

(10.09%)

Today

Watchers	19,612
52-Wk Low	$1.65
52-Wk High	$16.00

Market Cap	$4.62M
Volume (M)	113,860.00
52-Wk High	$16.00
52-Wk Low	$1.65

Fundamentals

Why Shares of Agile Therapeutics Jumped This WeekFool.com Headlines • 3 days ago

The women's healthcare company got an analyst upgrade...

Share to Feed

Agile Therapeutics (NASDAQ: AGRX) Upgraded To Buy Rating By Analysts At Maxim GroupAccesswire • 4 days ago

PRINCETON, NJ / ACCESSWIRE / September 28, 2023 / Maxim Group, a major investment bank, conducts and publishes stock analysis through its Equity Research team. The team has a strong reputation in the...

Agile Therapeutics upgraded to Buy from Hold at MaximThe Fly • 9 days ago

See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Agile Therapeutics, Inc. (NASDAQ:AGRX) Short Interest UpdateTicker Report • 16 days ago

Agile Therapeutics, Inc. (NASDAQ:AGRX Get Free Report) was the target of a significant drop in short interest during the month of August. As of August 31st, there was short interest totalling...

Agile Therapeutics, Inc. (NASDAQ:AGRX) Sees Large Decrease in Short InterestTicker Report • about 1 month ago

Agile Therapeutics, Inc. (NASDAQ:AGRX Get Free Report) saw a significant decline in short interest in the month of August. As of August 15th, there was short interest totalling 20,700 shares...

Short Interest in Agile Therapeutics, Inc. (NASDAQ:AGRX) Drops By 46.2%Zolmax • about 1 month ago

Agile Therapeutics, Inc. (NASDAQ:AGRX Get Free Report) was the recipient of a significant decrease in short interest in the month of August. As of August 15th, there was short interest totalling 20,700 shares, a decrease of 46.2% from the July 31st total of 38,500 shares. Currently, 1.1% of ...

Agile Therapeutics (NASDAQ:AGRX) Research Coverage Started at StockNews.comTicker Report • about 1 month ago

StockNews.com initiated coverage on shares of Agile Therapeutics (NASDAQ:AGRX Free Report) in a research note issued to investors on Thursday. The firm issued a hold rating on the specialty pharmaceutical companys stock. Separately, HC Wainwright reiterated a buy rating and set a $12....

Agile Therapeutics (NASDAQ:AGRX) Receives New Coverage from Analysts at StockNews.comZolmax • about 1 month ago

Stock analysts at StockNews.com assumed coverage on shares of Agile Therapeutics (NASDAQ:AGRX Get Free Report) in a research note issued to investors on Thursday. The brokerage set a hold rating on the specialty pharmaceutical companys stock. Separately, HC Wainwright reissued a buy rating and set a...

Agile Says It's On Track To Hit $25-$30 Million Net Annual Revenue After A Strong Performance In Its Second QuarterAccesswire • about 2 months ago

PRINCETON, NJ / ACCESSWIRE / August 17, 2023 / On August 9, Agile Therapeutics (NASDAQ:AGRX) released its second-quarter financial results, showing significant growth in revenue from its innovative...

Agile Therapeutics, Inc. (NASDAQ:AGRX) Short Interest Down 45.8% in JulyTicker Report • about 2 months ago

Agile Therapeutics, Inc. (NASDAQ:AGRX Get Free Report) was the recipient of a significant decline in short interest during the month of July. As of July 31st, there was short interest totalling 38,500 shares, a decline of 45.8% from the July 15th total of 71,000 shares. Approximately 1.4% of...